- Nov 5, 2009
- Lost a loved one
Please consider sending your House member a communiqué regarding potential cosponsorship of H.R. 4945, which would exempt NIV from Medicare's competitive bidding program for five years. Right now, CMS is scheduled to proceed in 2021 with applying a price-based methodology to selecting which DMEs can supply PALS, as well as kids and adults with muscular dystrophy, spinal cord injuries, severe COPD, etc. with BiPAPs, Trilogy, Astral and the like. This all came out of a GAO report showing suppliers were up-billing for patients who didn't need NIV (none of whom were PALS, obviously).